title: Melanoma antigens and targets for vaccination.
abstract: Metastatic melanoma is at present incurable by conventional therapy. However, encouraging improvements in patients survival have been obtained in clinical trials with melanoma vaccines as active specific immunotherapy. This review will discuss recent developments in melanoma vaccines.
authors.affiliation: RAFT Institute for Plastic Surgery, Mount Vernon Hospital, Middlesex.
authors.forename: N
authors.initials: N
authors.lastname: Kang
authors.forename: H
authors.initials: H
authors.lastname: Truman
authors.forename: R
authors.initials: R
authors.lastname: Sanders
authors.forename: J
authors.initials: J
authors.lastname: Kupsch
mesh_terms: D000951:Antigens, Neoplasm / Q000276:immunology*; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D016233:Immunotherapy, Active; D008545:Melanoma / Q000276:immunology / Q000517:prevention & control*; D009362:Neoplasm Metastasis; D012878:Skin Neoplasms / Q000276:immunology / Q000517:prevention & control*; D015996:Survival Rate
chemical_list: D000951:Antigens, Neoplasm; D019496:Cancer Vaccines